Cargando…
Genetic variants of CYP19 (aromatase) and breast cancer risk
Autores principales: | Nedelcheva Kristensen, V, Harada, N, Yoshimura, N, Haraldsen, E, Lønning, PE, Erikstein, B, Kåresen, R, Kristensen, T, Børresen-Dale, A-L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300851/ http://dx.doi.org/10.1186/bcr153 |
Ejemplares similares
-
Screening breast cancer patients for Norwegian ATM mutations
por: Laake, K, et al.
Publicado: (2000) -
Hypervariable area in the 5' flanking region of GSTP1, previously reported as a minisatellite repeat
por: Nedelcheva Kristensen, V, et al.
Publicado: (2000) -
HER-2 activation and TP53 inactivation as predictors of survival in breast cancer
por: Andersen, TI, et al.
Publicado: (2000) -
Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer
por: Yoshimura, Noriko, et al.
Publicado: (2004) -
Screening breast cancer patients for Norwegian ATM mutations
por: Laake, K, et al.
Publicado: (2000)